Motley Fool
The Pharmaceutical Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar.
📈
AI Sentiment
Highly Positive
8/10
AbbVie Inc. News
Latest updates and market news for ABBV
15 news
Nov 30 - Dec 6, 2025
Page 1
Investor's Business Daily
How Stock Of The Day Genmab Is Leveraging An $8 Billion Deal To Stoke Its Next Chapter
📊
AI Sentiment
Positive
6/10
Zacks
Pfizer (PFE) Up 3.9% Since Last Earnings Report: Can It Continue?
âž–
AI Sentiment
Neutral
5/10
Zacks
How Strong Is AbbVie's Immunology Franchise After Humira's LOE?
📈
AI Sentiment
Highly Positive
8/10
Pharma Voice
BeOne brought Brukinsa to the blood cancer mountaintop. Can it hit those heights again?
📈
AI Sentiment
Highly Positive
8/10
Zacks
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
📊
AI Sentiment
Positive
7/10
Simply Wall St.
Is It Too Late to Consider AbbVie After Its Strong Multi Year Share Price Rally?
📈
AI Sentiment
Highly Positive
8/10
Exec Edge
ReAlta Life Sciences Designates Dr. Howard Berman as Executive Chairman
📈
AI Sentiment
Highly Positive
8/10
PR Newswire
AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers
📈
AI Sentiment
Highly Positive
8/10
MT Newswires
Amneal Pharmaceuticals Wins FDA Approval for Generic Restasis, Plans Q1 Rollout
📊
AI Sentiment
Positive
6/10
GlobeNewswire
Amneal Announces U.S. FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05%
📈
AI Sentiment
Highly Positive
8/10
Benzinga
If You Invested $10K In AbbVie Stock 10 Years Ago, How Much Would You Have Now?
📈
AI Sentiment
Highly Positive
8/10
Simply Wall St.
AbbVie (NYSE:ABBV) Will Pay A Larger Dividend Than Last Year At $1.73
âž–
AI Sentiment
Neutral
5/10
Share this news page